NASDAQ:BPMC
Blueprint Medicines Corporation Stock News
$104.96
-1.68 (-1.58%)
At Close: May 17, 2024
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced top-line results from the Ph
Fly Intel: Wall Street's top stories for Tuesday BA;MMM;CAT;UPS;MRK;PFE;PEP;MNST;TSN;CAG;PPC;SAFM;HRL;SNDX;FFIV;CGNX;BPMC;HLIT;LRN
09:48am, Tuesday, 28'th Apr 2020
Fly Intel: Wall Street's top stories for Tuesday BA MMM CAT UPS MRK PFE PEP MNST TSN CAG PPC SAFM HRL SNDX FFIV CGNX BPMC HLIT LRN
Blueprint Medicines (NASDAQ:BPMC) and Menlo Therapeutics (NASDAQ:MNLO) Head-To-Head Review
06:22am, Monday, 27'th Apr 2020
Blueprint Medicines (NASDAQ:BPMC) and Menlo Therapeutics (NASDAQ:MNLO) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their
Menlo (MNLO) in Focus: Stock Moves 9.9% Higher
12:53pm, Friday, 24'th Apr 2020
Menlo (MNLO) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Menlo (MNLO) in Focus: Stock Moves 9.9% Higher
12:53pm, Friday, 24'th Apr 2020
Menlo (MNLO) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) announced that the China National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) of the precision the
Blueprint Medicines Corp (NASDAQ:BPMC) Expected to Post Quarterly Sales of $4.83 Million
08:50am, Tuesday, 21'st Apr 2020
Wall Street brokerages expect Blueprint Medicines Corp (NASDAQ:BPMC) to announce sales of $4.83 million for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided
Exane Derivatives Purchases 1,765 Shares of Blueprint Medicines Corp (NASDAQ:BPMC)
09:36am, Monday, 20'th Apr 2020
Exane Derivatives lifted its position in shares of Blueprint Medicines Corp (NASDAQ:BPMC) by 35,300.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange C
Baird's fresh biotech picks have catalysts straight ahead
06:53pm, Friday, 17'th Apr 2020
News is free at Seeking Alpha.This post is a Notable Call. Notable Calls are a Premium feature.To access this and other Notable Calls, try a free trial to Seeking Alpha Premium.
3 MedTech Stocks Likely to Have Braved Coronavirus Blow in Q1
01:12pm, Friday, 17'th Apr 2020
Despite the widespread coronavirus crisis, there are a few MedTech companies which are expected to have gained in the first quarter.
Top Research Reports for Comcast, Bristol-Myers & Walgreens
08:04pm, Thursday, 16'th Apr 2020
Top Research Reports for Comcast, Bristol-Myers & Walgreens
Should You Be Concerned About Blueprint Medicines Corporation's (NASDAQ:BPMC) Historical Volatility?
10:30am, Thursday, 16'th Apr 2020
If you own shares in Blueprint Medicines Corporation (NASDAQ:BPMC) then it's worth thinking about how it contributes...
Ironwood Pharma (IRWD) Gets a Hold Rating from Morgan Stanley
03:43pm, Wednesday, 15'th Apr 2020
Morgan Stanley analyst David Lebovitz maintained a Hold rating on Ironwood Pharma (IRWD) today and set a price target of $12.00. The company's shares
Ironwood Pharma (IRWD) Gets a Hold Rating from Morgan Stanley
03:43pm, Wednesday, 15'th Apr 2020
Morgan Stanley analyst David Lebovitz maintained a Hold rating on Ironwood Pharma (IRWD – Research Report) today and set a
Analysts Have Conflicting Sentiments on These Healthcare Companies: Rhythm Pharmaceuticals (RYTM), Genmab (GMAB) and Mylan (MYL)
03:39pm, Wednesday, 15'th Apr 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Rhythm Pharmaceuticals (RYTM), Genmab (GMAB) and Mylan
